3 new drugs of domestic origin under clinical phase III studies.
The KFDA said that 3 new drugs included Apitoxin inj. (Kuju) for the treatment of osteoarthritis, Yuvax III inj. (LG chemical) and Q-35 (Choongwe), a Quinolone ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
